0.84Open0.84Pre Close0 Volume181 Open Interest10.00Strike Price0.00Turnover0.00%IV-0.77%PremiumDec 20, 2024Expiry Date0.91Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma10.82Leverage Ratio--Theta--Rho--Eff Leverage--Vega
MiMedx Stock Discussion
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions. $MiMedx (MDXG.US)$